RS
GSK icon

R Squared’s GSK GSK Stock Holding History

R Squared’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$229K Sell
4,156
-1,669
-29% -$90.4K 0.13% 277
2025
Q4 		$286K Buy
+5,825
New +$272K 0.13% 245
2025
Q1 		– Sell
-5,170
Closed -$175K – 787
2024
Q4 		$175K Buy
+5,170
New +$186K 0.17% 135

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

R Squared's GSK Position: Q1 2026 in Review

R Squared reduced its GSK (GSK) stake by 29% in Q1 2026, selling an estimated $90.4K and leaving 4,156 shares worth $229K. The position accounts for 0.13% of the portfolio, ranked #277.

R Squared first reported a position in GSK in Q4 2024 and has held it in 3 quarters since. The position peaked at $286K in Q4 2025. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • R Squared held 4,156 shares of GSK worth $229K as of Q1 2026.
  • R Squared sold 1,669 GSK shares in Q1 2026, an estimated $90.4K.
  • GSK made up 0.13% of R Squared's portfolio in Q1 2026, its #277 holding.
  • R Squared first reported a position in GSK in Q4 2024 and has held it in 3 quarters since.
  • R Squared's GSK position peaked at $286K in Q4 2025.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on R Squared's 13F filing for Q1 2026, filed 29 Apr 2026.